These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18412925)

  • 21. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice].
    Olsson AG; Nilsson PM
    Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipid-altering efficacy and safety of ezetimibe/simvastatin coadministered with extended-release niacin in patients with type IIa or type IIb hyperlipidemia.
    Guyton JR; Brown BG; Fazio S; Polis A; Tomassini JE; Tershakovec AM
    J Am Coll Cardiol; 2008 Apr; 51(16):1564-72. PubMed ID: 18420099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of familial hypercholesterolemia with or without ezetimibe].
    Berthold HK; Nitschmann S
    Internist (Berl); 2008 Oct; 49(10):1274-6. PubMed ID: 18754087
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trial: comment on Ruggenenti et al.
    Sarigianni M; Katsiki N; Mikhailidis DP
    Diabetes Care; 2010 Oct; 33(10):e132; author reply e133. PubMed ID: 20876706
    [No Abstract]   [Full Text] [Related]  

  • 25. ENHANCE results: a surrogate trial that impacts beyond size and scope.
    Cardiovasc J Afr; 2008; 19(3):166-8. PubMed ID: 18568183
    [No Abstract]   [Full Text] [Related]  

  • 26. Premature release of data from clinical trials of ezetimibe.
    Califf RM; Harrington RA; Blazing MA
    N Engl J Med; 2009 Aug; 361(7):712-7. PubMed ID: 19675335
    [No Abstract]   [Full Text] [Related]  

  • 27. [New combination therapy. Up to 60% lower LDL cholesterol level].
    MMW Fortschr Med; 2004 May; 146(19):63. PubMed ID: 15357489
    [No Abstract]   [Full Text] [Related]  

  • 28. After ENHANCE: is more LDL cholesterol lowering even better?
    Stein EA
    Clin Chem; 2008 Jun; 54(6):940-2. PubMed ID: 18403568
    [No Abstract]   [Full Text] [Related]  

  • 29. Ezetimibe plus simvastatin cardiovascular outcomes study program.
    Padial LR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):17-25. PubMed ID: 18095904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapy and clinical trials.
    Krasuski RA
    Curr Opin Lipidol; 2008 Oct; 19(5):550-1. PubMed ID: 18769241
    [No Abstract]   [Full Text] [Related]  

  • 31. [Goal in hypercholesterolemia: lowering LDL cholesterol level by 50%].
    MMW Fortschr Med; 2005 Jul; 147(27-28):51. PubMed ID: 16041948
    [No Abstract]   [Full Text] [Related]  

  • 32. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Diamond GA; Kaul S
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532. PubMed ID: 18677796
    [No Abstract]   [Full Text] [Related]  

  • 33. [Even at LDL cholesterol 100mg/dl. "Every coronary disease patient has to receive a statin"].
    MMW Fortschr Med; 2003 Dec; 145(49):57. PubMed ID: 14963997
    [No Abstract]   [Full Text] [Related]  

  • 34. [Ezetimib and simvastatin. Cooperation at receptors of cholesterol metabolism].
    MMW Fortschr Med; 2005 Jul; 147(27-28):50. PubMed ID: 16041947
    [No Abstract]   [Full Text] [Related]  

  • 35. [Inegy: a powerful new medication for lowering LDL cholesterol].
    Rev Med Suisse; 2006 Jun; 2(70):1605. PubMed ID: 16838729
    [No Abstract]   [Full Text] [Related]  

  • 36. Amid lingering questions, FDA reprieves LDL cholesterol-lowering medication.
    Mitka M
    JAMA; 2009 Feb; 301(8):813-5. PubMed ID: 19244181
    [No Abstract]   [Full Text] [Related]  

  • 37. Critical lessons from the ENHANCE trial.
    Greenland P; Lloyd-Jones D
    JAMA; 2008 Feb; 299(8):953-5. PubMed ID: 18314439
    [No Abstract]   [Full Text] [Related]  

  • 38. [LDL cholesterol in cardiovascular risk patients should be as low as possible].
    MMW Fortschr Med; 2007 Oct; 149(41):44-5. PubMed ID: 17992793
    [No Abstract]   [Full Text] [Related]  

  • 39. Disappointing recent cholesterol-lowering drug trials: is it not time for a full reappraisal of the cholesterol theory?
    de Lorgeril M
    World Rev Nutr Diet; 2009; 100():80-89. PubMed ID: 19696530
    [No Abstract]   [Full Text] [Related]  

  • 40. Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study.
    Pauriah M; Struthers AD; Lang CC
    Cardiovasc Ther; 2008; 26(2):85-8. PubMed ID: 18485130
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.